Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1084-1084
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112563-112563
Open Access | Times Cited: 227
Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets
Hitesh Chopra, Protity Shuvra Dey, Debashrita Das, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4998-4998
Open Access | Times Cited: 170
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 155
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 149
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 137
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 134
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 125
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 124
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 111
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 111
Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer
Marzieh Ramezani Farani, Maryam Azarian, Hamid Heydari Sheikh Hossein, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 1305-1318
Open Access | Times Cited: 89
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 74
Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review
Glory Kah, Rahul Chandran, Heidi Abrahamse
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 639-639
Open Access | Times Cited: 54
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
Girish Kumar, Tarun Virmani, Ashwani Sharma, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 889-889
Open Access | Times Cited: 43
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy
Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 114-114
Open Access | Times Cited: 3
Herbal based nanoparticles as a possible and potential treatment of cancer: a review
Roshan Yadav, Himmat Singh Chawra, Gaurav Dubey, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access | Times Cited: 2
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
Enrico Gallo, Giovanni Smaldone, Luca Cimmino, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 263-263
Open Access | Times Cited: 2
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
Milad Ashrafizadeh, Ali Zarrabi, Sepideh Mirzaei, et al.
Food and Chemical Toxicology (2021) Vol. 157, pp. 112576-112576
Closed Access | Times Cited: 96
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 349-349
Open Access | Times Cited: 95
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi, Ali Zarrabi, Mohammad Gholami, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 62
Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer
Liguo Xie, Xiuling Ji, Qi Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112567-112567
Open Access | Times Cited: 62
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 4, pp. 355-382
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top